Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Karafin MS, DeSimone RA, Dvorak J, Metcalf RA, Pagano MB, Park YA, et al. Antibody Titers in Transfusion Medicine: A Critical Reevaluation of Testing Accuracy, Reliability, and Clinical Use. Arch Pathol Lab Med. 2023;147(12):1351-1359.

Assaad MA, Gundem G, Liechty B, Sboner A, Medina J, Papaemmanuil E, et al. The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer. Cold Spring Harb Mol Case Stud. 2023;9(4).

Forlenza CJ, Chadburn A, Giulino-Roth L. Primary Mediastinal B-Cell Lymphoma in Children and Young Adults. J Natl Compr Canc Netw. 2023;21(3):323-330.

Potter RF, Zhang K, Reimler B, Marino J, Muenks CE, Alvarado K, et al. Uncharacterized and lineage-specific accessory genes within the Proteus mirabilis pan-genome landscape. mSystems. 2023;8(4):e0015923.

Gereta S, Hung M, Alexanderani MK, Robinson BD, Hu JC. Evaluating the Learning Curve for In-office Freehand Cognitive Fusion Transperineal Prostate Biopsy. Urology. 2023;181:31-37.

Hwang JK, Magro CM, Lipner SR. Nail Unit Arteriovenous Hemangioma Presenting as Longitudinal Erythronychia. Skin Appendage Disord. 2023;9(4):300-305.

Callegari K, Dash S, Uchida H, Shingai Y, Liu C, Khodarkovskaya A, et al. Molecular profiling of the stroke-induced alterations in the cerebral microvasculature reveals promising therapeutic candidates. Proc Natl Acad Sci U S A. 2023;120(16):e2205786120.

Bhattacharya U, Kamran M, Manai M, Cristofanilli M, Ince TA. Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide. Cancers (Basel). 2023;15(2).

Boyraz B, Watkins JC, Young RH, Oliva E. Uterine Tumors Resembling Ovarian Sex Cord Tumors: A Clinicopathologic Study of 75 Cases Emphasizing Features Predicting Adverse Outcome and Differential Diagnosis. Am J Surg Pathol. 2023;47(2):234-247.

Stagg J, Golden E, Wennerberg E, Demaria S. The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Sci Immunol. 2023;8(85):eabq3015.